AB Health Ventures

AB Health Ventures, now operating under the name Cencora Ventures following AmerisourceBergen's rebranding to Cencora, is a $150 million venture capital fund. The fund focuses on early to mid-stage healthcare startups worldwide, prioritizing areas such as the future of pharmacy and distribution, clinical development, and commercialization of pharmaceuticals, healthcare provider solutions, and animal health. The fund leverages AmerisourceBergen's extensive expertise and global footprint to add value to its portfolio companies. It supports startups in rapidly prototyping solutions, conducting pilot tests, and accelerating commercialization. Notable recent investments include partnerships with TrakCel and Annexus Health, both leaders in their respective fields of cellular orchestration and healthcare technology. AB Health Ventures collaborates with Touchdown Ventures to manage its operations, ensuring that the fund's strategic and financial goals are met efficiently. The initiative aims to foster innovation in healthcare, driven by the belief that bold ideas and cutting-edge technologies can significantly improve patient outcomes and streamline healthcare delivery.